Praxis Precision Medicines, Inc. (NASDAQ: PRAX) reported Q3 EPS of ($0.18), $0.08 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $470 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Praxis Precision Medicines, Inc. (PRAX) click here.